Hutch News

Hutch News

Stories tagged 'George Georges'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 4, 2018

Increasing access to stem cell transplants; improving survival, QOL for those with scleroderma; biostatistician named chair-elect of AAAS Section on Statistics.

View story >


'Got my life back': Bone marrow transplant shows promise as Crohn's disease cure

New trial, old love fueling one woman's rejuvenation

July 8, 2015 | By Bill Briggs / Fred Hutch News Service

One year after receiving a bone marrow transplant to treat her severe Crohn's disease, Elise Elholm is eating new foods, enjoying new energy and feeling well or the first time in decades.

View story >


Cancer treatment quackery fuels concern among doctors, FDA

Be wary of possible side effects, drug interactions when using alternative health supplements, physicians caution

June 25, 2015 | By Bill Briggs / Fred Hutch News Service

A global crackdown on Internet merchants hawking counterfeit or bogus medicines and medical devices coincides with the surge of unproven cancer “cures” hawked by online sellers, federal health officials warn.

View story >


Stopping Stiff Person Syndrome: Alabama woman turns to stem cell transplant for help

Experimental Fred Hutch treatment aims to ease symptoms of rare, debilitating condition that causes rigid limbs, searing pain

Nov. 18, 2014 | By JoNel Aleccia / Fred Hutch News Service

A young Alabama woman with a rare disorder that leaves her body literally as stiff as a board is the first Fred Hutchinson Cancer Research Center patient to receive a stem cell transplant in hopes of helping – if not curing – her devastating condition.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.